G M Brodeur

发表

A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.

A T Look, A. Look, J. Biegel, 1995, Proceedings of the National Academy of Sciences of the United States of America.

International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma.

C. R. Pinkerton, B. Bernardi, A. Barrett, 1988, Progress in clinical and biological research.

High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.

A. Eggert, N. Ikegaki, G. Brodeur, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.

R. Ho, A. Eggert, N. Ikegaki, 2001, Cancer research.

Biology and genetics of human neuroblastomas.

J. Maris, P. White, M. Hogarty, 1997, Journal of pediatric hematology/oncology.

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

J Pritchard, F. Berthold, A. Evans, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.

G. Brodeur, G M Brodeur, C. Fong, 1987, Cancer genetics and cytogenetics.

Degradation of nuclear oncoproteins by the ubiquitin system in vitro.

A Ciechanover, A. Ciechanover, A. Orian, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

K K Matthay, D O Stram, D. Stram, 1999 .

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

J Khan, S L Cohn, J. Khan, 2009, British Journal of Cancer.

Molecular characterization and chromosomal localization of DRT (EPHT3): a developmentally regulated human protein-tyrosine kinase gene of the EPH family.

J A Biegel, C Allen, G M Brodeur, 1995, Human molecular genetics.

Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma.

A T Look, S L Cohn, A. Look, 1998, Journal of pediatric surgery.

Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.

N C Dracopoli, D. Housman, P. T. Merrill, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon

C. Plass, D. Smiraglia, J. Costello, 2000, Journal of medical genetics.

High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas.

G. Brodeur, G M Brodeur, J L Reiter, 1996, Genomics.

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.

A T Look, J J Shuster, A. Look, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.